Dear Colleagues and Friends,
After the enormous success of last year’s Symposium, we are excited to invite you to the 5th Annual International Headache Symposium in Israel January 29th, 2020.
This unique Headache Symposium will bring some of the world’s most recognized clinicians and researchers together to share their expertise and knowledge.
The latest research and treatments of Headache and Facial pain will be presented at the Symposium. The Symposium is also an ideal opportunity for the development of academic relationships that may promote research and practice for all participants in the daily care of patients.
We encourage all physicians who are interested in the field of Headache to join us and take an active part in this unique Headache Symposium.
Looking forward to seeing you all in Herzliya on Wednesday, January 29th, 2020.
Oved Daniel M.D.
Headache & Facial Pain Clinic, Director
Ramat Aviv Medical Center
Arieh Kuritzky M.D.
Vice chairman, department of Neurology
Beilinson Medical Center (Emeritus)
Stephen D. Silberstein, M.D., is Professor of Neurology and Director of the Jefferson Headache Center at Thomas Jefferson University. He is a Fellow of the American College of Physicians, the American Academy of Neurology, and the American Headache Society. He has served the American Headache Society as President, Treasurer, and Board of Directors member. In 2016, he was awarded a Lifetime Achievement Award by the American Headache Society. He has served on the Publications, Scientific, and Education Committees of the American Headache Society and was Co-Chairman of the Annual Scientific Meeting. Dr. Silberstein is an active member of the American Academy of Neurology and was Co-Director of the national and international Headache Guideline Project. He was the chairman of the International Headache Society meeting in Philadelphia in 2009. He is chairman of the headache research group of the World Federation of Neurology and President of the Philadelphia Headache Society.
Dr. Silberstein is the senior editor of the 8th edition of Wolff’s Headache and Other Head Pain, Associate Editor of Cephalalgia and CNS Drugs, and a present or prior member of the Editorial Board of Headache, Cephalalgia, Acta Neurologica Scandanavia, Journal of Neurology, Neurosurgery and Psychology, and Topics in Pain Management. He is also an ad hoc reviewer for many publications, and has more than 300 peer-reviewed publications to his credit.
Dr. Silberstein received his medical degree from the University of Pennsylvania. He did a medical internship at the Hospital of the University of Pennsylvania. After completing a fellowship in neurology at the National Hospital for Nervous Diseases in London, Dr. Silberstein completed a medicine/neurology residency at the Hospital of the University of Pennsylvania. He served as a pharmacology research associate in the Toxicology Laboratory of Clinical Science at the National Institutes of Mental Health and completed a neurology residency at the Hospital of the University of Pennsylvania.
Messoud Ashina is Professor of Neurology in the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. He is also Director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.
Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, functional neuroimaging, novel antimigraine drug targets, mechanism of migraine and action of antimigraine medications. He has authored over 400 papers, abstracts and book chapters on the topic of headache, including migraine.
Messoud Ashina serves as associated editor of Cephalalgia, co-editor of the Journal of Headache and Pain. Professor Ashina is President-elect of the International Headache Society and General Secretary of the European Headache Federation.
Rami Burstein, Ph.D. is the John Hedley-Whyte Professor of Anaesthesia and Neuroscience at Harvard Medical School, and the Vice Chairman of Research in the Department of Anesthesia and Critical Care at Beth Israel Deaconess Medical Center.
Professor Burstein is an appointed member of the Interagency Pain Research Coordinating Committee (IPRCC), which consists of representative from the NIH, CDC, FDA and the Department of Health and Human Services and whose mission is to implement the Patient Protection and Affordable Care Act; and the current (Co)-Chairman of the Scientific Program Committee for the International Headache Conference meeting in 2019 and the European Headache Federation Annual Meeting in 2018. He is a past member of the Board of Directors of both the American and the International Headache Societies.
Among Professor Burstein accomplishments are the discoveries of the spinohypothalamic tract, peripheral and central sensitization role in migraine pathophysiology and treatment, mechanisms of action of several anti-migraine drugs, the neurobiology of photophobia, and most recently, the glymphatic system role in migraine. Throughout the years, he has received numerous awards for his discoveries. These include the prestigious Javits Neuroscience Merit Award (National Advisory Neurological Disorder and Stroke Council), the Harold Wolff Awards for 2003 and 2005 (American Headache Society), the Cephalalgia Awards for best papers published in Cephalalgia in 2013 and 2015 (International Headache Society), the Seymour Diamond Lectureship Award in 2012 and 2015, and the 2010 Alan Edwards Center for Research on Pain Award )McGill University).
In the past 10 years, he has been serving as a reviewer for the NIH, the Welcome Trust, the Canadian Institute of Health Research, Science, the Dana Foundation Program in Brain and Immuno-imaging, Rita Allen Foundation, Brookdale Foundation, and the Ellison New Scholars Program in Aging.
Dr. Alan M. Rapoport is a Clinical Professor of Neurology at The David Geffen School of Medicine at UCLA, Los Angeles, California, where he teaches medical students, neurology residents and fellows.
He is a Past President of the International Headache Society (IHS) and the founder and Director-Emeritus of The New England Center for Headache, in Stamford, Connecticut. Board-certified in Neurology and Headache Medicine, he has co-authored more than 300 articles, chapters and posters on headache and other neurological diseases. He has lectured around the country and internationally to general physicians and headache specialists on all aspects of headache pathophysiology, diagnosis and treatment and has appeared many times on national radio and television programs, such as Today and Good Morning America.
He is an editor of Headache, CNS Drugs and Editor in Chief of Neurology Reviews. He reviews for many peer-reviewed journals such as Cephalalgia, Neurology, New England Journal of Medicine and Headache.
He has co-authored nine books on headache for patients, physicians, and nurses with Drs. Fred Sheftell and Stewart Tepper.
He is the Co-Founder and CEO of BonTriage, an IT company in Silicon Valley, California, dedicated to helping patients and doctors around the globe by collecting detailed patient histories on line and linking with an app that monitors patient progress and outcomes. The company has started with headache and is moving into sleep, depression, anxiety, chronic pain and other areas. BonTriage just launched a headache app on Apple to track headache and medications.
Dr. Rapoport has served on the Board of Directors of the American Headache Society (AHS) and is the immediate past President of the Fairfield County Neurological Society (Connecticut), the Founding President of the Headache Cooperative of New England (HCNE), the Founding Director of the Headache Cooperative of the Pacific (HCOP) and until June 2011 was the Chairman of the Education and Membership Committee of the International Headache Society (IHS).
Gisela Terwindt, Neurologist-biologist
Gisela Terwindt received her MSc in Biology and MD in Medicine at the University of Leiden, the Netherlands. Her PhD encompassed epidemiology and genetics of migraine, with the discovery of the first migraine gene. She is Assprof. and Consultant Neurologist, at the Department of Neurology, Leiden University Medical Center (LUMC), Netherlands, and director of the Headache Clinic. She is chair of the Scientific- and Migraine Guideline Committee of the Dutch Headache Society. She was Committee member for the ICHD-III Classification and is chair of the IHS Clinical Guideline Committee. She has published >250 scientific papers and several book chapters on headache and migraine. She received a prestigious personal grant from the Dutch Organisation of Scientific Research (VIDI-award).
Her research interest is to unravel neurobiological and molecular triggering mechanisms leading to migraine attacks, and to identify treatment targets for the acute treatment and prevention of attacks and disease-chronification. In addition, her group is studying the pathogenesis of rare monogenic disorders such as Familial Hemiplegic Migraine and Cerebral Hereditary Angiopathies which may serve as genetic models to study the pathogenesis of migraine but also improve mechanistic insight in the pathophysiology of other common neurovascular disorders, including stroke and dementia. With this she is increasingly involved in the migraine-stroke relationship with a special focus on women, and has a special interest to study female-specific trigger factors and complications in migraine.
Cancellations must be received by email to: firstname.lastname@example.org
Cancellations received until January 22nd, 2020 – no cancellation fee
Cancellations received from January 23rd, 2020 – full registration fee with no refund. This includes non-arrivals.
Payment of registration fees should be made in USD for international participants and in NIS for local participants, by credit card only – Visa, MasterCard or American Express are accepted.